Four Colorado physicians are named in a lawsuit settlement involving pharmaceutical company Biohaven, which allegedly paid ...
Eli Lilly also responded to the President's tariff warnings by investing $27 billion to construct four manufacturing ...
With this latest announcement, Lilly has committed to investing more than $50 billion in U.S. manufacturing since 2020.
Pfizer's Q4/24 results showed significant improvements, with total revenue up 21.9% YoY and adjusted diluted EPS increasing ...
Eli Lilly and Company, UnitedHealth Group, AbbVie, Walmart, Johnson & Johnson, Natera, and Gilead Sciences are the seven Medical stocks to watch today, according to MarketBeat’s stock screener tool.
California made a big bet on producing its own insulin. There’s no ‘date certain’ for delivery
California dedicated $100 to manufacturing insulin for diabetic residents. That effort is taking longer than Gov. Gavin ...
A bevy of major corporations and foreign countries have pledged to pour billions into the U.S. since President Donald Trump ...
Key Takeaways AbbVie agreed to license a weight-loss drug in development from Danish biotech firm Gubra.AbbVie said it will ...
The stagflation specter is spooking traders today, wiping out the risk-on move that was buoying stocks and weighing on board ...
Aspen Pharmacare posted a 5% rise in half-year earnings on Monday and said it expects double-digit revenue and core profit ...
(Reuters) -Pfizer CEO Albert Bourla said on Monday the drugmaker might move overseas manufacturing to its existing plants in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results